Portfolio Update

RNS Number : 4257M

Intl. Biotechnology Trust PLC

27 April 2018

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

Portfolio Update as at 31 March 2018

Net Assets	£219m
Net Assets per share	584p
Share price	548p
Total value of unquoted investments	£21m
Total number of portfolio companies	90
Dividend	4% of NAV per annum

Top Ten Quoted Investments

Company Name	% NAV
Array	4.7
Biogen	4.2
Celgene	4.2
Neurocrine	4.2
Regeneron	3.7
Genmab	3.7
Sage	3.6
Vertex	3.6
Gilead	3.3
Exelixis	3.2
	-----------
Total	38.4

Geographical Allocation	% NAV
US & Canada	83
Europe & UK	17
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	91
Unquoted	9
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	36
Mid Cap =USD1-10BN	37
Small Cap <USD1BN	27
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	42
CNS	18
Rare diseases	11
Inflammation	7
Ophthalmology	6
Infectious Diseases	4
Metabolic	3
Medtech	3
Other	6
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

27 APRIL 2018

 

END

 

 

PFUBBGDSRUDBGIR